Navigation Links
Insmed Announces Financial Results for Second Quarter and Six-Months Ended June 30, 2008
Date:8/8/2008

- - - 576

Research and development 5,536 3,691 10,777 9,796

Selling, general and

administrative 1,493 1,153 2,975 6,535

Loss on investments 54 - 446 -

Total expenses 7,083 4,844 14,198 16,907

Operating loss (4,435) (2,569) (9,233) (12,972)

Interest income 96 224 375 525

Interest expense (328) (155) (682) (306)

Net loss $(4,667) $(2,500) $(9,540) $(12,753)

Basic and diluted net loss

per share $(0.04) $(0.02) $(0.08) $(0.12)

Shares used in computing

basic and diluted net loss

per share 121,989 113,577 121,989 107,486

INSMED INCORPORATED

Consolidated Statements of Cash Flows

(in thousands - unaudited)

Six Months Ended

June 30,

2008 2007

Operating activities

Net loss $(9,540) $(12,753)

Adjustments to reconcile net loss to net cash

used in operating activities:

Depreciation and amortization 562 168

Stock based compensation expense 298 129

Stock options issued for services 140 39

Realized loss on investments 446 -

Changes in operating assets and liabilities:

Accounts receivable 200 241

Invent
'/>"/>

SOURCE Insmed Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. Insmed Appoints Dennis M. Lanfear to Board Of Directors
2. Insmed Awarded $2.1 Million by Muscular Dystrophy Association
3. Insmed to Appeal Delisting Notification From Nasdaq
4. Insmed President Interviewed for Follow-On Biologics Podcast: Insmed Inc. President Steve Glover Discusses Safe and Effective Biologic Therapies and Reduced Costs with The American Magazine
5. Insmed CEO Issues Statement on White House FY09 Budget and FDA Statements on Follow-On Biologics
6. Insmed to Host Fourth Quarter and Full-Year 2007 Conference Call
7. Insmed Announces Listing Transfer from Nasdaq Global Market to Nasdaq Capital Market
8. Insmed Announces Fourth Quarter and Full-Year 2007 Financial Results
9. Insmed Announces Additional Information in Compliance With NASDAQ Rules
10. Insmed Selected to Complete Congressional Questionnaire Regarding the Potential Establishment of a Follow-On Biologics Regulatory Pathway
11. Insmed to Present at CBI Follow-On Biologics Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... 20, 2014 Neurotrope, Inc. (OTCQB: NTRP) ... call to provide an update on Company activities. ... timeDial-in numbers:(888) 505-4369 (U.S. and Canada) or (719) ... www.neurotropebioscience.com , under "Investor Relations"The teleconference replay will ... September 2, 2014 at (888) 203-1112 (U.S. and ...
(Date:8/20/2014)... 2014 The 6th Annual Arrowhead ... on October 29-30 in San Francisco, CA. This year’s ... government researchers and clinicians focused on addressing and solving ... In the twelve years since the sequencing of the ... introduced with pharmacogenetic information in the label and molecular ...
(Date:8/20/2014)... WriteResult®, a leading provider of Electronic Patient ... its myPROpad™ ePRO tablet with the addition of a ... most widely used and well-respected Patient Reported Outcome (PRO) ... is used during clinical trials and in other health ... used to demonstrate Health-Related Quality of Life outcomes (HRQoL) ...
(Date:8/19/2014)... 19, 2014 Research and Markets  has announced the ... Strategic Business Report" report to their offering. ... Supplies in US$ Thousands by the following Product Segments: Media, Sera, ... the US, Canada , Japan ... and Latin America . Annual estimates and forecasts ...
Breaking Biology Technology:Neurotrope To Host Conference Call 26th Annual Personalized and Precision Medicine Conference Bringing Together Thought Leaders to Discuss Clinical Implementation, Dx Reimbursement, Big Data, and Sequencing 2EQ-5D™ Assessment Now Available for iPad 2Global Cell and Tissue Culture Supplies - Strategic Business Report 2014 2
... Offers New Intravaginal Foam Technology with Improved Usability & ... ... May 13 Despite the high incidence,of women,s health conditions that ... ovules, a recent survey,found that an alarming majority of women find ...
... Has Four Phase 2 Trials Underway, MONTVALE, N.J., ... has dosed the first patient in a 160-patient Phase ... BREAK (Beginning a,Randomized Evaluation of the A.G.E. [Advanced Glycation ... randomized,double-blind, placebo controlled study to assess the effect of ...
... Technologies,Inc. (Amex: PTN ) today reported its ... 2008 and announced new strategic objectives as part ... development,programs. Palatin will continue to develop products targeting ... and,cardiovascular fields, including acute hospital care products for ...
Cached Biology Technology:72% of Women Are Dissatisfied With Their Current Treatment of Vaginal Infection, Survey Finds 2Synvista Therapeutics Announces Initiation of the BREAK Study of Alagebrium for Diastolic Heart Failure 2Synvista Therapeutics Announces Initiation of the BREAK Study of Alagebrium for Diastolic Heart Failure 3Synvista Therapeutics Announces Initiation of the BREAK Study of Alagebrium for Diastolic Heart Failure 4Palatin Technologies Announces New Strategic Objectives and Reports Third Quarter 2008 Financial Results 2Palatin Technologies Announces New Strategic Objectives and Reports Third Quarter 2008 Financial Results 3Palatin Technologies Announces New Strategic Objectives and Reports Third Quarter 2008 Financial Results 4Palatin Technologies Announces New Strategic Objectives and Reports Third Quarter 2008 Financial Results 5Palatin Technologies Announces New Strategic Objectives and Reports Third Quarter 2008 Financial Results 6Palatin Technologies Announces New Strategic Objectives and Reports Third Quarter 2008 Financial Results 7
(Date:8/21/2014)... -- Nine researchers from Beth Israel Deaconess ... in "The World,s Most Influential Scientific Minds 2014," ... Thomson Reuters ScienceWatch, a web resource for science metrics ... recognized as among the most influential "are performing and ... the advancement of their science," according to a Thomson ...
(Date:8/21/2014)... Fram Strait is a key region in the global oceanic ... and Svalbard warm Atlantic water flows to the north into ... water masses and sea ice push their way out of ... the Atlantic water cools here on its way to the ... water caused in this manner drives the global band of ...
(Date:8/21/2014)... Wednesday, Oct. 18-22, 2014 , WHERE: , ... San Diego, CA 92101 , WHAT: , ... of the latest research in human genetics. Examples ... high-scoring abstracts on rare genetic variants in health ... treatment for sun sensitivity (Saturday, Oct. 18, 5:30-7:30 ...
Breaking Biology News(10 mins):BIDMC researchers named among 'the most influential scientific minds' 2BIDMC researchers named among 'the most influential scientific minds' 3Arctic sea ice influenced force of the Gulf Stream 2Arctic sea ice influenced force of the Gulf Stream 3American Society of Human Genetics 2014 Annual Meeting 2
... 8, 2009 / b3c newswire / - West ... and systems for injectable drug delivery, and Vetter, ... manufacturing of prefilled application systems, have introduced a ... products. , “The Vetter/West WFI syringe combines the ...
... Ore Oregon Health & Science University researchers, along ... uncovering new information about the mind by studying the ... this research will one day provide new tools for ... treatments. The researchers, latest findings are published in the ...
... lesson from Australia,s Great Barrier Reef is that we ... turn protects us. That,s the message from Professor ... Coral Reef Studies and James Cook University who today ... for his pioneering work in understanding how ecosystems develop ...
Cached Biology News:Prefilled WFI Syringe Provides a High-Quality Solution for Drug Reconstitution 2Prefilled WFI Syringe Provides a High-Quality Solution for Drug Reconstitution 3OHSU researchers study the idling brain 2A big lesson from the reef 2A big lesson from the reef 3
...
... Anti-HMGN2/HMG-17 Immunogen : ... Tris-glycine, pH7.4, 5mg/ml BSA, 0.15M ... the addition of glycerol to ... by immunoblot on acid extracts ...
...
... different human fetal normal tissues are ... upon request. Customers can choose ... set, and pay 70% of the ... P Set products are for research ...
Biology Products: